Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

Study Identifier
192024-067
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Hypotrichosis
  • Study Drug
  • bimatoprost solution 0.03%
  • bimatoprost vehicle solution
  • Phase
    Phase 3
    Sex
    Female & Male
    Age
    20+ years

    Protocol Summary

    This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes following chemotherapy treatment.

    Study Locations

    Location
    Status
    Location
    Chiba, Japan
    Status
    Not applicable